Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Equity (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Return on Equity for 15 consecutive years, with 0.04% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity rose 42.0% to 0.04% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.04%, a 42.0% increase, with the full-year FY2024 number at 0.35%, down 36.0% from a year prior.
  • Return on Equity was 0.04% for Q3 2025 at Xtant Medical Holdings, up from 0.1% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.06% in Q3 2023 to a low of 0.39% in Q3 2024.
  • A 5-year average of 0.17% and a median of 0.19% in 2021 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: skyrocketed 1401bps in 2021, then crashed -45bps in 2024.
  • Xtant Medical Holdings' Return on Equity stood at 0.16% in 2021, then crashed by -63bps to 0.25% in 2022, then skyrocketed by 105bps to 0.01% in 2023, then plummeted by -3076bps to 0.37% in 2024, then skyrocketed by 110bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Return on Equity are 0.04% (Q3 2025), 0.1% (Q2 2025), and 0.28% (Q1 2025).